Primrose Nyamayaro1, Dixon Chibanda1,2, Reuben N Robbins3, James Hakim4, Hetta Gouse5. 1. Department of Psychiatry, University of Zimbabwe, Harare, Zimbabwe. 2. Centre for Global Mental Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. 3. New York State Psychiatric Institute, Columbia University, New York, United States. 4. Department of Medicine, University of Zimbabwe, Harare, Zimbabwe. 5. Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
Abstract
Objective: People living with HIV (PLWH) are at risk for HIV-Associated Neurocognitive Disorders (HAND)/Neurocognitive Impairment (NCI). HIV prevalence in Sub-Saharan Africa (SSA) is high, but neuropsychological screening and testing for NCI among HIV-infected individuals is not done frequently. This systematic review aims to establish how NCI among HIV-infected individuals is being assessed in SSA, if and how the tests are adapted, if norms exist and identify personnel who administer them.Method: We searched PubMed, Medline, EBSCO, PsycINFO, and Web of Science. Two reviewers screened the articles for inclusion and risk of bias. We included studies from SSA with a comprehensive neuropsychological assessment battery. Results: We retrieved 212 articles and 23 articles met inclusion criteria. The most commonly used tests were the Color Trails Test 1, Color Trails Test 2, and the WAIS III Digit Symbol Test. Some tests were translated into French (Cameroon), Luganda (Uganda), Chichewa (Malawi), isiXhosa (South Africa), and Afrikaans (South Africa). Some verbal learning tests were adapted to reflect culturally appropriate language. Test administrators were either non-specialized personnel supervised by clinical neuropsychologists or clinical psychologists. Conclusion: Overall, the tests used are similar to the tests being used globally to assess NCI among HIV-infected individuals and there is a general consistency across countries. However, there is generally a lack of norms for the tests and the process of adaptation is not always well described. Future research should establish whether these tests measure neuropsychological constructs as successfully as they do in western populations where the tests were developed.
Objective: People living with HIV (PLWH) are at risk for HIV-Associated Neurocognitive Disorders (HAND)/Neurocognitive Impairment (NCI). HIV prevalence in Sub-Saharan Africa (SSA) is high, but neuropsychological screening and testing for NCI among HIV-infected individuals is not done frequently. This systematic review aims to establish how NCI among HIV-infected individuals is being assessed in SSA, if and how the tests are adapted, if norms exist and identify personnel who administer them.Method: We searched PubMed, Medline, EBSCO, PsycINFO, and Web of Science. Two reviewers screened the articles for inclusion and risk of bias. We included studies from SSA with a comprehensive neuropsychological assessment battery. Results: We retrieved 212 articles and 23 articles met inclusion criteria. The most commonly used tests were the Color Trails Test 1, Color Trails Test 2, and the WAIS III Digit Symbol Test. Some tests were translated into French (Cameroon), Luganda (Uganda), Chichewa (Malawi), isiXhosa (South Africa), and Afrikaans (South Africa). Some verbal learning tests were adapted to reflect culturally appropriate language. Test administrators were either non-specialized personnel supervised by clinical neuropsychologists or clinical psychologists. Conclusion: Overall, the tests used are similar to the tests being used globally to assess NCI among HIV-infected individuals and there is a general consistency across countries. However, there is generally a lack of norms for the tests and the process of adaptation is not always well described. Future research should establish whether these tests measure neuropsychological constructs as successfully as they do in western populations where the tests were developed.
Authors: Travis M Scott; Hetta Gouse; John Joska; Kevin G F Thomas; Michelle Henry; Anna Dreyer; Reuben N Robbins Journal: Appl Neuropsychol Adult Date: 2018-09-28 Impact factor: 2.248
Authors: Ned C Sacktor; Matthew Wong; Noeline Nakasujja; Richard L Skolasky; Ola A Selnes; Seggane Musisi; Kevin Robertson; Justin C McArthur; Allan Ronald; Elly Katabira Journal: AIDS Date: 2005-09-02 Impact factor: 4.177
Authors: Ned Sacktor; Noeline Nakasujja; Richard L Skolasky; Mona Rezapour; Kevin Robertson; Seggane Musisi; Elly Katabira; Allan Ronald; David B Clifford; Oliver Laeyendecker; Thomas C Quinn Journal: Clin Infect Dis Date: 2009-09-01 Impact factor: 9.079
Authors: C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak Journal: Neurology Date: 2002-12-24 Impact factor: 9.910
Authors: Noeline Nakasujja; Sachiko Miyahara; Scott Evans; Anthony Lee; Seggane Musisi; Elly Katabira; Kevin Robertson; Allan Ronald; David B Clifford; Ned Sacktor Journal: Neurology Date: 2012-12-26 Impact factor: 9.910
Authors: Ahmad M Yakasai; Mustafa I Gudaji; Hamza Muhammad; Aliyu Ibrahim; Lukman F Owolabi; Daiyabu A Ibrahim; Musa Babashani; Muhammad S Mijinyawa; Musa M Borodo; Abayomi S Ogun; Abdulrazaq G Habib Journal: Neurol Res Int Date: 2015-08-09
Authors: Hetta Gouse; Catherine J Masson; Michelle Henry; Anna Dreyer; Reuben N Robbins; Greg Kew; John A Joska; Leslie London; Thomas D Marcotte; Kevin G F Thomas Journal: J Acquir Immune Defic Syndr Date: 2022-04-15 Impact factor: 3.771
Authors: Lucette A Cysique; Emilia Łojek; Theodore Ching-Kong Cheung; Breda Cullen; Anna Rita Egbert; Jonathan Evans; Maite Garolera; Natalia Gawron; Hetta Gouse; Karolina Hansen; Paweł Holas; Sylwia Hyniewska; Ewa Malinowska; Bernice A Marcopulos; Tricia L Merkley; Jose A Muñoz-Moreno; Clare Ramsden; Christian Salas; Sietske A M Sikkes; Ana Rita Silva; Imane Zouhar Journal: J Int Neuropsychol Soc Date: 2021-08-09 Impact factor: 3.114
Authors: Otsetswe Musindo; Lydiah Krabbendam; Joan Mutahi; Miguel Pérez García; Paul Bangirana; Manasi Kumar Journal: Child Adolesc Psychiatry Ment Health Date: 2022-04-27 Impact factor: 7.494